<DOC>
	<DOCNO>NCT00422422</DOCNO>
	<brief_summary>Initial study child epilepsy evaluate pharmacokinetics , safety , tolerability preliminary efficacy adjunctive treatment brivaracetam , develop dose adaptation future study .</brief_summary>
	<brief_title>Open-label , Pharmacokinetic , Safety Efficacy Study Adjunctive Brivaracetam Children With Epilepsy .</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Clinical diagnosis epilepsy Subject least 1 seizure ( type ) 3 week first visit Stable dose 13 concomitant antiepileptic drug Pregnant nursing female Concomitant use Levetiracetam Epilepsy secondary Progressive cerebral disease/tumor neurodegenerative disease History status epilepticus Clinically significant acute chronic illness , underlie disease medication condition History suicide attempt</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Brivaracetam</keyword>
	<keyword>Epilepsy</keyword>
	<keyword>Child</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Adolescents</keyword>
</DOC>